Atlas Trials

Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis

Clinical trial NCT02767297 · COMPLETED

Trial details

NCT number
NCT02767297
Sponsor
Flatley Discovery Lab LLC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2016-04-01
Primary completion
2016-10-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.